Thoracic oncology
Symposium
NELSON: the Trafalgar of lung cancer screening?
Aims : to present NELSON results 1 year after the first data were released, consensus data on participant selection and consensus data on nodule handling to minimise the false positive rate; to discuss the cost-effectiveness of lung cancer screening; to address the ethical dilemma of screening current smokers.
Target audience :
General practitioner, Pathologist, Patient, Policy maker, Radiologist, Thoracic oncologist, Thoracic surgeon, Trainee, Adult pulmonologist/Clinician
Methods :
Imaging, Surgery
14:45
Update on NELSON including its cost-effectiveness analysis
H. De Koning(Rotterdam, Netherlands)
COI
1
1553
15:09
Screening for lung cancer: who should (not) be enrolled?
C. Thomson(Boston, United States)
COI
2
1554
15:33
(Not) screening smokers: a patient’s view
J. Rawlinson(Tipton, United Kingdom)
COI
-
Description
3
1555
15:57
How do we handle nodules to minimise the false positive rate?
D. Baldwin(Nottingham (Nottinghamshire), United Kingdom)
COI
4
1556
16:21
Introduction on the ESR/ERS statement on low-dose lung cancer screening
H. Kauczor(Heidelberg, Germany)
COI
5
1557
. . .
